Cell Culture – Increased Production of Seasonal Influenza Vaccines
Cell culture is fast emerging as an important tool for diagnosing and clinically treating various disease such as cancer and Alzheimer’s. Companies are focusing on diversifying their cell depository and enhancing their expertise by laying major emphasis on recruitment of highly trained professionals in order to gain a competitive edge in the market. The European Collection of Authenticated Cell Cultures (ECACC) is serving the patent depository for Europe for carrying out research by acting as international depository authority. According to VF Bioscience SAS, cell culture technique is also gaining popularity in the field of food and beverages, a trend that is estimated to gain significant traction in 2017. Furthermore, cell culture are also gaining preference as an important ingredient in production of high quality plant actives.
Cell culture process can include various complications such as obtaining fully traceable botanical extracts and raw material supply. Furthermore, increasing focus on ensuring regulatory compliance related to environmental sustainability can hamper efficacy of the product. To overcome these complications in 2017, in place of using wild or field-grown plants, researchers at ABResearch srl utilized the callus cultures and cell suspension cultures for better results. According to News Medical Life-sciences, in 2017, researchers are inclined towards developing culture model that can be used in early treatment of age-related macular degeneration (AMD). AMD is the third major cause for total vision loss and also more prevalent in elderly people.
The global cell culture market was valued at US$ 12,251.3 million in 2015 and is expected to witness a robust CAGR of 7.1% during the forecast period (2016 – 2024).
Figure 1. Global Cell Culture Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024
Source: Coherent Market Insights Analysis (2017)
To have a snippet of the report, request Report Sample
High Investment in research and development by biotechnological companies
Players in the global cell culture market are making major investments in R&D to introduce advanced products used in the cell culture process owing to rise in number of application and better return on investment. Furthermore, companies are inclined towards novel product development. For instance, Biovest International, in 2009, has developed a product named AutovaxID-C, which is expected to reshape the biologic production made in the industry. The product favors the automated cell growth by replacing conventional cell growth chambers that use to acquire a large space in the laboratory. Various other factors such as increasing prevalence of chronic diseases, high importance of tissue or organ replacement with cell culture process, and increasing demand for antibody production are in turn projected to fuel cell culture market growth. Also, rise in prevalence of age-related macular degeneration is expected to underpin the cell culture market growth. Eye conditions such as diabetic retinopathy in tune with rise in number of diabetic patients globally in turn creates a conducive environment for growth of the cell culture market. AMD ranks third with a prevalence of around 8.7% globally in 2015, according to W.H.O.
Major Player’s acquisitions are expected to fuel product diversification
An advanced and schematic integration of major players, followed by various acquisitions in cell culture market is fueling the frequency of product introduction in biotechnology and molecular biology field. Also, Advancements in mammalian cell culture techniques under recombinant protein production is propelling the cell culture market to new heights. In 2013, according to MDPI AG., Journal of Pharmaceutical, between 2006 and 2011, around 15 recombinant protein therapeutics were approved by U.S. FDA. Rise in number of biologics have spurred demand for biosimilars, which in turn is expected to fuel growth of the market for cell culture in the near future. In recent times, the global cell culture market has witnessed a high level of strategic mergers and acquisitions leading to development and advancement of new cell culture products. For instance:
Increasing number of research collaborations is expected to improve the time-to-market of highly effective and advanced products.
The technique of growing cells outside the human body itself is a significant advancement in scientific research. Cell culture technique has been around since mid-20th century and the field is continuously expanding into various areas of pharmaceutical research and development such as cancer and immunotherapy. Endeavor to improve the drug bioavailability and therapeutic efficacy has led to better research outcomes in cancer and health screening techniques. The ability to develop continuous cell lines has enabled mass production of desired organ cells for research and treatment benefits. Cell culture offers an excellent model system for studying the normal physiology and biochemistry, drug effects and drug screening. Being an exploratory research field, use of reagents, instruments and other consumables is very critical to support its advancements.
Increasing research on personalized therapies and stem cells is driving growth of the market for cell culture. Also, growing organ transplantation and biobanking of cells tissues and organs is driving growth of the market for cell culture instruments and consumables. According to the Global Observatory on Donation and Transplantation (GODT), around 119,873 organs were transplanted worldwide in 2014 (1.81% increase over 2013). The demand-supply gap of organ transplantation is a major problem faced globally. In the U.S. alone, nearly 118,652 patients are waiting for organ transplant (U.S. Department of Health & Human Service, 2017). Using cell culture technique to differentiate cells of liver, heart and nervous system would aid in the treatment of millions of such patients globally. Further, advent of 3D cell culture technique has enabled researchers to understand the body physiology and biological systems much better. Moreover, the spheroid formation and scaffold-based techniques are driving demand for 3D cell culture products.
This report segments the global cell culture market on the basis of products, applications, end user, and geography. On the basis of product type, the market is segmented into consumables and instruments. The consumables market is categorized into media, sera, and reagents. The instruments market is categorized into culture systems, incubators, pipette, roller bottles, cryostorage equipment and biosafety cabinets. The end users segment comprises academic and research institutes and commercial pharma and biotech product manufacturers. For comprehensive understanding of market dynamics, the global cell culture market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Request Report Sample for more Professional and Technical Insights.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 45 market data tables and 30 figures on "Cell Culture Market - Global forecast to 2024”
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.